Anand Shrikant Dighe, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Decision Support Systems, Clinical | 13 | 2024 | 1178 | 3.650 |
Why?
|
| Clinical Laboratory Information Systems | 9 | 2019 | 108 | 2.210 |
Why?
|
| Laboratories | 8 | 2022 | 463 | 1.690 |
Why?
|
| Medical Order Entry Systems | 6 | 2024 | 523 | 1.330 |
Why?
|
| Paraproteinemias | 2 | 2023 | 252 | 1.250 |
Why?
|
| Pathology, Clinical | 8 | 2015 | 377 | 1.180 |
Why?
|
| Clinical Laboratory Techniques | 7 | 2020 | 749 | 1.060 |
Why?
|
| Creatinine | 2 | 2024 | 1917 | 0.940 |
Why?
|
| Cystatin C | 1 | 2024 | 272 | 0.830 |
Why?
|
| Glomerular Filtration Rate | 2 | 2024 | 2228 | 0.750 |
Why?
|
| Glycyrrhetinic Acid | 1 | 2020 | 15 | 0.730 |
Why?
|
| Glycyrrhiza | 1 | 2020 | 11 | 0.720 |
Why?
|
| Mineralocorticoids | 1 | 2020 | 37 | 0.720 |
Why?
|
| Laboratories, Hospital | 5 | 2017 | 192 | 0.680 |
Why?
|
| Transferrin | 1 | 2020 | 284 | 0.650 |
Why?
|
| Hypothyroidism | 2 | 2014 | 667 | 0.620 |
Why?
|
| Deficiency Diseases | 1 | 2017 | 74 | 0.570 |
Why?
|
| Hypesthesia | 1 | 2017 | 106 | 0.560 |
Why?
|
| Hyperaldosteronism | 1 | 2020 | 252 | 0.560 |
Why?
|
| Addison Disease | 1 | 2017 | 48 | 0.550 |
Why?
|
| Hypokalemia | 2 | 2020 | 152 | 0.530 |
Why?
|
| Medical Errors | 5 | 2013 | 1262 | 0.490 |
Why?
|
| Copper | 1 | 2017 | 369 | 0.480 |
Why?
|
| Cost Savings | 2 | 2020 | 915 | 0.480 |
Why?
|
| Electronic Health Records | 4 | 2022 | 4879 | 0.480 |
Why?
|
| Spinal Cord Diseases | 1 | 2017 | 293 | 0.480 |
Why?
|
| Hyponatremia | 1 | 2017 | 279 | 0.460 |
Why?
|
| Thyrotropin | 2 | 2014 | 834 | 0.450 |
Why?
|
| Zinc | 1 | 2017 | 677 | 0.430 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 2013 | 94 | 0.420 |
Why?
|
| Anemia, Pernicious | 1 | 2012 | 15 | 0.400 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2020 | 1568 | 0.400 |
Why?
|
| Anemia, Hemolytic | 1 | 2013 | 164 | 0.400 |
Why?
|
| Anorexia | 1 | 2012 | 153 | 0.390 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2013 | 209 | 0.390 |
Why?
|
| Erythrocyte Indices | 1 | 2012 | 143 | 0.380 |
Why?
|
| Receptors, Interferon | 4 | 1995 | 115 | 0.370 |
Why?
|
| Thyrotoxicosis | 1 | 2012 | 85 | 0.370 |
Why?
|
| Academic Medical Centers | 6 | 2017 | 2784 | 0.370 |
Why?
|
| Diagnosis, Differential | 9 | 2020 | 13021 | 0.370 |
Why?
|
| Decision Trees | 1 | 2012 | 509 | 0.350 |
Why?
|
| Paralysis | 1 | 2012 | 250 | 0.350 |
Why?
|
| Graves Disease | 1 | 2012 | 239 | 0.350 |
Why?
|
| Safety Management | 2 | 2007 | 765 | 0.340 |
Why?
|
| Systems Integration | 2 | 2018 | 430 | 0.340 |
Why?
|
| Antibodies, Viral | 7 | 2022 | 3215 | 0.330 |
Why?
|
| Artificial Intelligence | 2 | 2022 | 2666 | 0.330 |
Why?
|
| Reagent Strips | 1 | 2009 | 40 | 0.320 |
Why?
|
| Rickets | 1 | 2009 | 70 | 0.310 |
Why?
|
| Chemistry, Clinical | 2 | 2006 | 64 | 0.290 |
Why?
|
| Hospitals, University | 2 | 2006 | 570 | 0.290 |
Why?
|
| Information Services | 1 | 2008 | 239 | 0.280 |
Why?
|
| Muscle Weakness | 3 | 2017 | 413 | 0.280 |
Why?
|
| Estradiol | 2 | 2005 | 1952 | 0.280 |
Why?
|
| Diagnostic Tests, Routine | 3 | 2018 | 790 | 0.280 |
Why?
|
| Acute Kidney Injury | 2 | 2019 | 1936 | 0.270 |
Why?
|
| Manuals as Topic | 1 | 2006 | 99 | 0.270 |
Why?
|
| Urinalysis | 1 | 2009 | 370 | 0.270 |
Why?
|
| Information Management | 1 | 2006 | 100 | 0.260 |
Why?
|
| Utilization Review | 2 | 2012 | 384 | 0.250 |
Why?
|
| Liability, Legal | 1 | 2007 | 209 | 0.250 |
Why?
|
| Humans | 72 | 2024 | 768970 | 0.240 |
Why?
|
| Diagnostic Services | 1 | 2004 | 34 | 0.240 |
Why?
|
| Clinical Medicine | 1 | 2006 | 145 | 0.240 |
Why?
|
| Autoanalysis | 1 | 2004 | 70 | 0.240 |
Why?
|
| Multiple Myeloma | 1 | 2023 | 5196 | 0.240 |
Why?
|
| Hydrocortisone | 3 | 2020 | 1841 | 0.240 |
Why?
|
| Paraproteins | 1 | 2004 | 38 | 0.240 |
Why?
|
| Antibodies, Neutralizing | 4 | 2022 | 2009 | 0.230 |
Why?
|
| Vitamin B 12 Deficiency | 2 | 2017 | 119 | 0.230 |
Why?
|
| Aldosterone | 2 | 2020 | 881 | 0.220 |
Why?
|
| Erythrocytes | 1 | 2013 | 2421 | 0.220 |
Why?
|
| Research Design | 2 | 2018 | 6214 | 0.220 |
Why?
|
| Blood Coagulation Tests | 1 | 2004 | 270 | 0.220 |
Why?
|
| Inhibins | 1 | 2004 | 210 | 0.220 |
Why?
|
| Blood Cell Count | 1 | 2024 | 406 | 0.220 |
Why?
|
| Hepatitis Viruses | 1 | 2002 | 15 | 0.210 |
Why?
|
| Algorithms | 8 | 2022 | 14201 | 0.210 |
Why?
|
| Hepatitis Antibodies | 1 | 2002 | 67 | 0.210 |
Why?
|
| Clinical Protocols | 1 | 2008 | 1445 | 0.200 |
Why?
|
| Blood Chemical Analysis | 2 | 2020 | 436 | 0.200 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2005 | 727 | 0.200 |
Why?
|
| Quality Assurance, Health Care | 2 | 2019 | 2182 | 0.200 |
Why?
|
| Bilirubin | 1 | 2004 | 438 | 0.200 |
Why?
|
| Databases, Factual | 1 | 2018 | 8094 | 0.200 |
Why?
|
| Luteinizing Hormone | 1 | 2005 | 822 | 0.200 |
Why?
|
| Jaundice | 2 | 2013 | 95 | 0.200 |
Why?
|
| Hepatitis, Viral, Human | 1 | 2002 | 141 | 0.200 |
Why?
|
| Health Services | 2 | 2012 | 755 | 0.200 |
Why?
|
| Interferon-gamma | 8 | 1998 | 3163 | 0.200 |
Why?
|
| Reflex | 1 | 2024 | 375 | 0.200 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2023 | 289 | 0.190 |
Why?
|
| Efficiency | 2 | 2020 | 480 | 0.190 |
Why?
|
| Information Storage and Retrieval | 1 | 2006 | 831 | 0.180 |
Why?
|
| Patients | 1 | 2007 | 908 | 0.170 |
Why?
|
| Thyroxine | 2 | 2014 | 665 | 0.170 |
Why?
|
| Artifacts | 1 | 2009 | 1942 | 0.170 |
Why?
|
| Diagnostic Errors | 1 | 2007 | 1281 | 0.160 |
Why?
|
| Hematologic Tests | 1 | 2020 | 239 | 0.160 |
Why?
|
| Vitamin D Deficiency | 1 | 2009 | 1388 | 0.160 |
Why?
|
| Patient Care | 1 | 2024 | 629 | 0.150 |
Why?
|
| Ferritins | 2 | 2024 | 600 | 0.150 |
Why?
|
| Immune Evasion | 1 | 2022 | 376 | 0.150 |
Why?
|
| Internet | 2 | 2008 | 3112 | 0.150 |
Why?
|
| Vitamin E Deficiency | 1 | 2017 | 30 | 0.150 |
Why?
|
| Efficiency, Organizational | 3 | 2015 | 699 | 0.150 |
Why?
|
| Cholesterol, HDL | 1 | 2004 | 1820 | 0.150 |
Why?
|
| Ventricular Fibrillation | 1 | 2020 | 537 | 0.150 |
Why?
|
| Models, Statistical | 1 | 2012 | 5110 | 0.150 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2017 | 62 | 0.140 |
Why?
|
| Kidney Transplantation | 1 | 2012 | 4265 | 0.140 |
Why?
|
| Cooperative Behavior | 1 | 2004 | 1515 | 0.140 |
Why?
|
| Viral Vaccines | 1 | 2022 | 596 | 0.140 |
Why?
|
| False Positive Reactions | 2 | 2009 | 963 | 0.130 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2017 | 247 | 0.130 |
Why?
|
| Osmolar Concentration | 1 | 2017 | 657 | 0.130 |
Why?
|
| Fatal Outcome | 1 | 2020 | 1836 | 0.130 |
Why?
|
| Diplopia | 1 | 2017 | 217 | 0.130 |
Why?
|
| Interprofessional Relations | 1 | 2001 | 997 | 0.120 |
Why?
|
| Point-of-Care Systems | 1 | 2024 | 1240 | 0.120 |
Why?
|
| Urine | 1 | 2017 | 362 | 0.120 |
Why?
|
| Reference Values | 4 | 2010 | 4940 | 0.120 |
Why?
|
| Critical Care | 2 | 2019 | 2716 | 0.120 |
Why?
|
| Vaccines, Synthetic | 3 | 2022 | 622 | 0.120 |
Why?
|
| Vitamin D | 1 | 2009 | 3311 | 0.120 |
Why?
|
| Computational Biology | 3 | 2018 | 3562 | 0.120 |
Why?
|
| Confusion | 1 | 2017 | 278 | 0.120 |
Why?
|
| Macrophages, Peritoneal | 1 | 1995 | 244 | 0.120 |
Why?
|
| Hoarseness | 1 | 2014 | 63 | 0.120 |
Why?
|
| Anemia | 3 | 2013 | 1517 | 0.110 |
Why?
|
| Vomiting | 1 | 2017 | 655 | 0.110 |
Why?
|
| Rhabdomyolysis | 1 | 2014 | 150 | 0.110 |
Why?
|
| Data Mining | 1 | 2018 | 563 | 0.110 |
Why?
|
| Aspartate Aminotransferases | 1 | 2014 | 414 | 0.110 |
Why?
|
| Pharyngitis | 1 | 2014 | 222 | 0.100 |
Why?
|
| Creatine Kinase | 1 | 2014 | 684 | 0.100 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2020 | 997 | 0.100 |
Why?
|
| Paralysis, Hyperkalemic Periodic | 1 | 2012 | 5 | 0.100 |
Why?
|
| Male | 18 | 2024 | 365203 | 0.100 |
Why?
|
| Electromyography | 1 | 2017 | 1401 | 0.100 |
Why?
|
| Muscle Cramp | 1 | 2012 | 33 | 0.100 |
Why?
|
| Polypharmacy | 1 | 2014 | 307 | 0.100 |
Why?
|
| Thyroid Hormones | 1 | 2014 | 407 | 0.100 |
Why?
|
| Middle Aged | 12 | 2024 | 223737 | 0.100 |
Why?
|
| Iron | 1 | 2020 | 1814 | 0.100 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2013 | 219 | 0.100 |
Why?
|
| Sarcoidosis | 1 | 2017 | 535 | 0.090 |
Why?
|
| Paresthesia | 1 | 2012 | 160 | 0.090 |
Why?
|
| Hospitalization | 1 | 2011 | 10847 | 0.090 |
Why?
|
| Bradycardia | 1 | 2012 | 305 | 0.090 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2022 | 1642 | 0.090 |
Why?
|
| Adrenal Insufficiency | 1 | 2012 | 195 | 0.090 |
Why?
|
| Neoplasms, Experimental | 2 | 1998 | 1231 | 0.090 |
Why?
|
| Weight Loss | 2 | 2012 | 2721 | 0.090 |
Why?
|
| Workflow | 1 | 2015 | 859 | 0.090 |
Why?
|
| Seroepidemiologic Studies | 2 | 2022 | 405 | 0.090 |
Why?
|
| Radiography | 2 | 2012 | 6991 | 0.080 |
Why?
|
| Delayed Diagnosis | 1 | 2013 | 468 | 0.080 |
Why?
|
| Cranial Fontanelles | 1 | 2009 | 10 | 0.080 |
Why?
|
| Cross Reactions | 2 | 2022 | 828 | 0.080 |
Why?
|
| Flow Cytometry | 1 | 2020 | 5906 | 0.080 |
Why?
|
| Gastric Bypass | 1 | 2017 | 824 | 0.080 |
Why?
|
| Calcium Carbonate | 1 | 2009 | 62 | 0.080 |
Why?
|
| Diarrhea, Infantile | 1 | 2009 | 100 | 0.080 |
Why?
|
| Nitrites | 1 | 2009 | 156 | 0.080 |
Why?
|
| Chorionic Gonadotropin | 1 | 2010 | 458 | 0.080 |
Why?
|
| Sepsis | 1 | 2022 | 2610 | 0.080 |
Why?
|
| Sickle Cell Trait | 1 | 2009 | 86 | 0.080 |
Why?
|
| Hospital Departments | 1 | 2008 | 135 | 0.070 |
Why?
|
| Hypophosphatemia | 1 | 2009 | 93 | 0.070 |
Why?
|
| Ergocalciferols | 1 | 2009 | 110 | 0.070 |
Why?
|
| Th1 Cells | 4 | 1997 | 1042 | 0.070 |
Why?
|
| Hematologic Neoplasms | 1 | 2020 | 1907 | 0.070 |
Why?
|
| Crystallization | 1 | 2009 | 520 | 0.070 |
Why?
|
| Pulmonary Emphysema | 1 | 2013 | 689 | 0.070 |
Why?
|
| Immunoglobulin M | 2 | 2020 | 1528 | 0.070 |
Why?
|
| Adult | 13 | 2022 | 223851 | 0.070 |
Why?
|
| Female | 18 | 2024 | 397515 | 0.070 |
Why?
|
| Equipment Contamination | 1 | 2009 | 183 | 0.070 |
Why?
|
| Fatigue | 1 | 2014 | 1557 | 0.070 |
Why?
|
| Hypocalcemia | 1 | 2009 | 205 | 0.070 |
Why?
|
| Terminology as Topic | 1 | 2014 | 1541 | 0.070 |
Why?
|
| Dyspnea | 1 | 2014 | 1352 | 0.070 |
Why?
|
| Physicians | 1 | 2004 | 4607 | 0.070 |
Why?
|
| Aged, 80 and over | 3 | 2024 | 59739 | 0.070 |
Why?
|
| Continuity of Patient Care | 1 | 2013 | 1076 | 0.070 |
Why?
|
| Th2 Cells | 3 | 1997 | 1079 | 0.070 |
Why?
|
| Retrospective Studies | 4 | 2024 | 81903 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2022 | 3811 | 0.070 |
Why?
|
| Blood Glucose | 2 | 2012 | 6435 | 0.060 |
Why?
|
| Diabetes Complications | 1 | 2012 | 1320 | 0.060 |
Why?
|
| Quality Control | 1 | 2008 | 836 | 0.060 |
Why?
|
| Online Systems | 1 | 2006 | 182 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2020 | 3813 | 0.060 |
Why?
|
| Electroencephalography | 1 | 2020 | 6317 | 0.060 |
Why?
|
| Interleukin-12 | 3 | 1997 | 577 | 0.060 |
Why?
|
| Methods | 1 | 2005 | 1066 | 0.060 |
Why?
|
| Computer Communication Networks | 1 | 2006 | 295 | 0.060 |
Why?
|
| User-Computer Interface | 1 | 2011 | 1406 | 0.060 |
Why?
|
| Documentation | 1 | 2011 | 917 | 0.060 |
Why?
|
| Potassium | 1 | 2008 | 1315 | 0.060 |
Why?
|
| Massachusetts | 3 | 2020 | 8894 | 0.060 |
Why?
|
| Menstruation | 1 | 2005 | 310 | 0.050 |
Why?
|
| Immunosorbents | 1 | 2022 | 21 | 0.050 |
Why?
|
| Medication Adherence | 1 | 2014 | 2192 | 0.050 |
Why?
|
| Hematology | 1 | 2006 | 243 | 0.050 |
Why?
|
| High-Throughput Screening Assays | 2 | 2021 | 942 | 0.050 |
Why?
|
| Lung | 2 | 2012 | 10099 | 0.050 |
Why?
|
| Sensitivity and Specificity | 3 | 2021 | 14752 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2015 | 6291 | 0.050 |
Why?
|
| Respiratory Tract Infections | 1 | 2009 | 1014 | 0.050 |
Why?
|
| Serologic Tests | 1 | 2002 | 382 | 0.040 |
Why?
|
| Breast Feeding | 1 | 2009 | 1364 | 0.040 |
Why?
|
| Vitamins | 1 | 2009 | 1638 | 0.040 |
Why?
|
| Emergency Service, Hospital | 2 | 2022 | 7957 | 0.040 |
Why?
|
| Reference Standards | 1 | 2004 | 1014 | 0.040 |
Why?
|
| Asymptomatic Infections | 1 | 2021 | 136 | 0.040 |
Why?
|
| Kidney Failure, Chronic | 1 | 2012 | 2493 | 0.040 |
Why?
|
| Remote Sensing Technology | 1 | 2021 | 93 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2015 | 3860 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 3253 | 0.040 |
Why?
|
| Blood Specimen Collection | 1 | 2021 | 238 | 0.040 |
Why?
|
| Specimen Handling | 1 | 2024 | 708 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 4 | 1997 | 6232 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2012 | 6002 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 20776 | 0.040 |
Why?
|
| Receptors, Interleukin | 2 | 1997 | 243 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2012 | 6413 | 0.040 |
Why?
|
| Coronavirus | 1 | 2020 | 156 | 0.040 |
Why?
|
| Health Personnel | 2 | 2022 | 3383 | 0.040 |
Why?
|
| Fingers | 1 | 2021 | 512 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2002 | 620 | 0.040 |
Why?
|
| Cryoelectron Microscopy | 1 | 2022 | 649 | 0.040 |
Why?
|
| Lymphocyte Count | 1 | 2020 | 794 | 0.040 |
Why?
|
| Aged | 4 | 2024 | 171786 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2022 | 1952 | 0.040 |
Why?
|
| Kidney | 1 | 2012 | 7058 | 0.030 |
Why?
|
| Vesicular stomatitis Indiana virus | 2 | 1996 | 93 | 0.030 |
Why?
|
| Immunoglobulin A | 1 | 2020 | 992 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2004 | 1407 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2012 | 4860 | 0.030 |
Why?
|
| Skilled Nursing Facilities | 1 | 2021 | 406 | 0.030 |
Why?
|
| Genes, MHC Class I | 2 | 1995 | 236 | 0.030 |
Why?
|
| Smoking | 1 | 2013 | 9094 | 0.030 |
Why?
|
| Software | 1 | 2010 | 4479 | 0.030 |
Why?
|
| Fertilization in Vitro | 1 | 2004 | 1303 | 0.030 |
Why?
|
| Transfection | 2 | 1994 | 5763 | 0.030 |
Why?
|
| Prospective Studies | 4 | 2022 | 54962 | 0.030 |
Why?
|
| Seizures | 1 | 2009 | 3000 | 0.030 |
Why?
|
| Data Collection | 1 | 2004 | 3324 | 0.030 |
Why?
|
| Tumor Escape | 1 | 1998 | 372 | 0.030 |
Why?
|
| Epitopes | 1 | 2022 | 2529 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2019 | 1645 | 0.030 |
Why?
|
| Polysaccharides | 1 | 2022 | 1024 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 1995 | 6512 | 0.030 |
Why?
|
| Neoplasm Transplantation | 2 | 1998 | 2018 | 0.030 |
Why?
|
| Mice, Inbred C3H | 1 | 1995 | 915 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2022 | 2360 | 0.030 |
Why?
|
| Asthma | 1 | 2013 | 6293 | 0.030 |
Why?
|
| Neoplasms | 2 | 2021 | 22389 | 0.030 |
Why?
|
| Unnecessary Procedures | 1 | 2017 | 419 | 0.030 |
Why?
|
| Interferon-alpha | 2 | 1996 | 910 | 0.030 |
Why?
|
| Kidney Diseases | 1 | 2024 | 2100 | 0.030 |
Why?
|
| Physician Executives | 1 | 2014 | 140 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2022 | 1894 | 0.030 |
Why?
|
| Work | 1 | 2014 | 195 | 0.030 |
Why?
|
| Cholecystitis, Acute | 1 | 2013 | 81 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 1993 | 229 | 0.030 |
Why?
|
| Triage | 1 | 2020 | 997 | 0.030 |
Why?
|
| Genes, MHC Class II | 1 | 1993 | 433 | 0.020 |
Why?
|
| Trans-Activators | 3 | 1997 | 2858 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2022 | 5404 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 706 | 0.020 |
Why?
|
| Boston | 1 | 2004 | 9377 | 0.020 |
Why?
|
| Pelvic Neoplasms | 1 | 2013 | 250 | 0.020 |
Why?
|
| Pathology, Molecular | 1 | 2014 | 329 | 0.020 |
Why?
|
| Mice, Transgenic | 4 | 1997 | 9565 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 2 | 1998 | 6131 | 0.020 |
Why?
|
| Organ Specificity | 1 | 1995 | 1970 | 0.020 |
Why?
|
| United States | 3 | 2011 | 73186 | 0.020 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2010 | 83 | 0.020 |
Why?
|
| Lipopolysaccharides | 2 | 1996 | 2222 | 0.020 |
Why?
|
| Health Planning Guidelines | 1 | 2011 | 153 | 0.020 |
Why?
|
| Cytokines | 3 | 2020 | 7453 | 0.020 |
Why?
|
| Genotype | 1 | 2024 | 13048 | 0.020 |
Why?
|
| Hospitals, General | 1 | 2014 | 810 | 0.020 |
Why?
|
| Vaccination | 1 | 2022 | 3438 | 0.020 |
Why?
|
| Protein Binding | 1 | 2022 | 9344 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2010 | 575 | 0.020 |
Why?
|
| Mice, SCID | 1 | 1994 | 2631 | 0.020 |
Why?
|
| Interferon Type I | 1 | 1993 | 569 | 0.020 |
Why?
|
| Base Sequence | 3 | 1996 | 12430 | 0.020 |
Why?
|
| Mice | 8 | 1998 | 82072 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 4568 | 0.020 |
Why?
|
| Incidental Findings | 1 | 2013 | 697 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2001 | 3628 | 0.020 |
Why?
|
| Animals | 9 | 2002 | 169335 | 0.020 |
Why?
|
| DNA | 1 | 2022 | 7214 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 3 | 1996 | 22379 | 0.020 |
Why?
|
| Plasmids | 1 | 1993 | 2269 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2020 | 10115 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2013 | 937 | 0.020 |
Why?
|
| Medical Informatics | 1 | 2014 | 742 | 0.020 |
Why?
|
| Molecular Sequence Data | 3 | 1996 | 17629 | 0.020 |
Why?
|
| Abdominal Pain | 1 | 2013 | 1070 | 0.020 |
Why?
|
| Immunoassay | 1 | 2010 | 746 | 0.020 |
Why?
|
| Hospitals | 1 | 2020 | 3904 | 0.020 |
Why?
|
| Receptors, Interleukin-12 | 2 | 1997 | 26 | 0.020 |
Why?
|
| Infant | 1 | 2009 | 36556 | 0.020 |
Why?
|
| Quality of Health Care | 1 | 2001 | 4339 | 0.020 |
Why?
|
| Critical Illness | 1 | 2019 | 2754 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 1995 | 2211 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2016 | 2008 | 0.020 |
Why?
|
| Comorbidity | 1 | 2020 | 10592 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2019 | 3800 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1997 | 3612 | 0.020 |
Why?
|
| Brain | 1 | 2012 | 27453 | 0.020 |
Why?
|
| Information Dissemination | 1 | 2013 | 1141 | 0.020 |
Why?
|
| Antigens, CD | 1 | 1995 | 4032 | 0.020 |
Why?
|
| Logistic Models | 1 | 2020 | 13318 | 0.020 |
Why?
|
| Cardiomyopathies | 1 | 2017 | 2057 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 1993 | 2149 | 0.010 |
Why?
|
| Gene Expression | 2 | 1995 | 7603 | 0.010 |
Why?
|
| Cell Differentiation | 3 | 1997 | 11684 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 7478 | 0.010 |
Why?
|
| Incidence | 1 | 2022 | 21547 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2024 | 24333 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2013 | 4926 | 0.010 |
Why?
|
| Cell Line | 2 | 1995 | 15604 | 0.010 |
Why?
|
| Neutrophils | 1 | 1995 | 3785 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1995 | 4528 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 15951 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2024 | 18068 | 0.010 |
Why?
|
| Blood Protein Electrophoresis | 1 | 2001 | 65 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 1995 | 4794 | 0.010 |
Why?
|
| DNA-Binding Proteins | 2 | 1997 | 9618 | 0.010 |
Why?
|
| Toxicology | 1 | 2001 | 103 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1993 | 10765 | 0.010 |
Why?
|
| Pandemics | 1 | 2021 | 8749 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 26395 | 0.010 |
Why?
|
| Expert Testimony | 1 | 2001 | 266 | 0.010 |
Why?
|
| Methylcholanthrene | 1 | 1998 | 30 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 41808 | 0.010 |
Why?
|
| Blood Coagulation Disorders | 1 | 2001 | 350 | 0.010 |
Why?
|
| Signal Transduction | 3 | 1997 | 23653 | 0.010 |
Why?
|
| Immunocompetence | 1 | 1998 | 138 | 0.010 |
Why?
|
| Molecular Biology | 1 | 2001 | 573 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2010 | 5151 | 0.010 |
Why?
|
| Protein Sorting Signals | 1 | 1998 | 274 | 0.010 |
Why?
|
| STAT4 Transcription Factor | 1 | 1997 | 94 | 0.010 |
Why?
|
| Mutation | 1 | 2022 | 30266 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 1997 | 2433 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 1994 | 10276 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 2013 | 4919 | 0.010 |
Why?
|
| Adolescent | 1 | 2005 | 89244 | 0.010 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 1996 | 152 | 0.010 |
Why?
|
| Medical Records | 1 | 2001 | 1411 | 0.010 |
Why?
|
| Reimbursement Mechanisms | 1 | 2001 | 677 | 0.010 |
Why?
|
| TYK2 Kinase | 1 | 1995 | 38 | 0.010 |
Why?
|
| DNA Probes | 1 | 1996 | 543 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 2001 | 1309 | 0.010 |
Why?
|
| STAT1 Transcription Factor | 1 | 1996 | 343 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2020 | 65480 | 0.010 |
Why?
|
| Time Factors | 1 | 2015 | 40261 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2011 | 5375 | 0.010 |
Why?
|
| Gene Targeting | 1 | 1996 | 841 | 0.010 |
Why?
|
| Janus Kinase 2 | 1 | 1995 | 560 | 0.010 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 1997 | 977 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 1995 | 1157 | 0.010 |
Why?
|
| Spleen | 1 | 1997 | 2294 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 2001 | 2258 | 0.010 |
Why?
|
| Ligands | 1 | 1995 | 3283 | 0.000 |
Why?
|
| Pregnancy | 1 | 2010 | 30265 | 0.000 |
Why?
|
| Down-Regulation | 1 | 1995 | 2942 | 0.000 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1998 | 2960 | 0.000 |
Why?
|
| Graft Rejection | 1 | 1998 | 4492 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1995 | 5505 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1997 | 12806 | 0.000 |
Why?
|
| Adenocarcinoma | 1 | 1998 | 6401 | 0.000 |
Why?
|
| Mice, Knockout | 1 | 1996 | 14484 | 0.000 |
Why?
|
| Proteins | 1 | 1995 | 6011 | 0.000 |
Why?
|
| Rats | 1 | 1996 | 23786 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 1998 | 13594 | 0.000 |
Why?
|